4-(4-hydroxy-1,4-dimethyl-2-cyclohexen-1-yl)-3-(hydroxymethyl)-4-methyl-2-cyclopenten-1-one

Metabolite details

Identifier

MKMOUQVTTUPKSO-UHFFFAOYSA-N

InChI Key

MKMOUQVTTUPKSO-UHFFFAOYSA-N

IUPAC name

Preferred name

4-(4-hydroxy-1,4-dimethyl-2-cyclohexen-1-yl)-3-(hydroxymethyl)-4-methyl-2-cyclopenten-1-one

INN name

—

Synonym

FS4 toxin

ChEBI

CHEBI:138771

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Metabolomic Insights into the Browning of the Peel of Bagging ‘Rui Xue’ Apple Fruit
• Efficacy of Zhuyu Pill Intervention in a Cholestasis Rat Model: Mutual Effects on Fecal Metabolism and Microbial Diversity
• Transcriptional memory of dFOXO activation in youth curtails later-life mortality
• Effects of MeJA on Arabidopsis metabolome under endogenous JA deficiency
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning
• Control_vs_CF_high
• RU-_Control_vs_RU+_Switch
• WT_no_treatment_vs_opr3_8h
• Control_vs_ZYP_High_Dose
• Male_19_days_vs_Male_1_day